Emergent role of the fractalkine axis in dissemination of peritoneal metastasis from epithelial ovarian carcinoma

被引:0
作者
H Gurler Main
J Xie
G G Muralidhar
O Elfituri
H Xu
A A Kajdacsy-Balla
M V Barbolina
机构
[1] University of Illinois at Chicago,Department of Biopharmaceutical Sciences
[2] University of Illinois at Chicago,Department of Pathology
来源
Oncogene | 2017年 / 36卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Epithelial ovarian carcinoma is the most common cause of death from gynecologic cancers largely due to advanced, relapsed and chemotherapy-resistant peritoneal metastasis, which is refractory to the currently used treatment approaches. Mechanisms supporting advanced and relapsed peritoneal metastasis are largely unknown, precluding development of more effective targeted therapies. In this study, we investigated the function of a potentially targetable fractalkine axis in the formation and the development of advanced and relapsed peritoneal metastasis and its impact on patients’ outcomes. Our mouse model studies support a role for the fractalkine receptor (CX3CR1) in the initiation of peritoneal adhesion important for recolonization of relapsed peritoneal metastasis. We show that downregulation of CX3CR1 results in reduction of metastatic burden at several peritoneal sites commonly colonized by advanced and relapsed metastatic ovarian carcinoma. We show that the chemokine fractalkine (CX3CL1), an activating ligand of CX3CR1, regulates organ-specific peritoneal colonization. High expression of CX3CR1 correlates with significantly shorter survival, specifically in post-menopausal patients with advanced and terminal stages of the disease. Taken together, our studies support a key regulatory role for the fractalkine axis in advanced and relapsed peritoneal metastasis in epithelial ovarian carcinoma.
引用
收藏
页码:3025 / 3036
页数:11
相关论文
共 50 条
  • [21] Role of Farletuzumab in Epithelial Ovarian Carcinoma
    Jelovac, Danijela
    Armstrong, Deborah K.
    CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (25) : 3812 - 3815
  • [22] MANAGEMENT OF PERITONEAL METASTASES IN EPITHELIAL OVARIAN, FALLOPIAN TUBE AND PRIMARY PERITONEAL CARCINOMA
    Gao, Yunong
    ANTICANCER RESEARCH, 2015, 35 (07) : 4301 - 4302
  • [23] MOC31PE immunotoxin - targeting peritoneal metastasis from epithelial ovarian cancer
    Andersson, Yvonne
    Haavardtun, Synne Ihler
    Davidson, Ben
    Dorum, Anne
    Fleten, Karianne G.
    Fodstad, Oystein
    Flatmark, Kjersti
    ONCOTARGET, 2017, 8 (37) : 61800 - 61809
  • [24] The Risk of Ovarian Malignancy Algorithm (ROMA) as a Predictive Marker of Peritoneal Dissemination in Epithelial Ovarian Cancer Patients
    Ikeda, Yuji
    Hasegawa, Kosei
    Kurosaki, Akira
    Miyara, Akiko
    Hanaoka, Tatsuya
    Shintani, Daisuke
    Imai, Yuichi
    Nishikawa, Tadaaki
    Oda, Katsutoshi
    Fujiwara, Keiichi
    ONCOLOGY RESEARCH AND TREATMENT, 2015, 38 (06) : 276 - 281
  • [25] A Role for CXCR4 in Peritoneal and Hematogenous Ovarian Cancer Dissemination
    Figueras, Agnes
    Alsina-Sanchis, Elisenda
    Lahiguera, Alvaro
    Abreu, Manuel
    Muinelo-Romay, Laura
    Moreno-Bueno, Gema
    Casanovas, Oriol
    Graupera, Mariona
    Matias-Guiu, Xavier
    Vidal, August
    Villanueva, Alberto
    Vinals, Francesc
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (02) : 532 - 543
  • [26] Fractalkine Receptor CX3CR1 Is Expressed in Epithelial Ovarian Carcinoma Cells and Required for Motility and Adhesion to Peritoneal Mesothelial Cells
    Kim, Mijung
    Rooper, Lisa
    Xie, Jia
    Kajdacsy-Balla, Andre A.
    Barbolina, Maria V.
    MOLECULAR CANCER RESEARCH, 2012, 10 (01) : 11 - 24
  • [27] Safety and efficacy of thalidomide in recurrent epithelial ovarian and peritoneal carcinoma
    Chan, John K.
    Manuel, Michael R.
    Ciaravino, Giuseppe
    Cheung, Michael K.
    Husain, Amreen
    Teng, Nelson N. H.
    GYNECOLOGIC ONCOLOGY, 2006, 103 (03) : 919 - 923
  • [28] Suppressive effect of bevacizumab on peritoneal dissemination from gastric cancer in a peritoneal metastasis model
    Takuya Imaizumi
    Keishiro Aoyagi
    Motoshi Miyagi
    Kazuo Shirouzu
    Surgery Today, 2010, 40 : 851 - 857
  • [29] Suppressive effect of bevacizumab on peritoneal dissemination from gastric cancer in a peritoneal metastasis model
    Imaizumi, Takuya
    Aoyagi, Keishiro
    Miyagi, Motoshi
    Shirouzu, Kazuo
    SURGERY TODAY, 2010, 40 (09) : 851 - 857
  • [30] The role of interleukin 8 in the peritoneal metastasis of gastric carcinoma
    Kim, BS
    Yonemura, Y
    Yook, JH
    Oh, ST
    Kim, JC
    Park, KC
    Lee, JD
    3RD INTERNATIONAL GASTRIC CANCER CONGRESS, 1999, : 835 - 839